A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing

Ben Mulhearn
, Danyang Li
, Fionnuala McMorrow
, Hui Lu
, Neil J. McHugh
, Sarah L. Tansley

Royal National Hospital for Rheumatic Diseases

Research output: Contribution to journal › Article › peer-review

23 Citations (SciVal)

166 Downloads (Pure)

1 results

Finished
Establishing molecular differences between anti-TIF1¿ associated and not associated with malignancy in patients with idiopathic inflammatory myopathies
McHugh, N. (PI) & Tansley, S. (CoI)
The Academy of Medical Sciences
2/09/19 → 5/09/22
Project: UK charity